Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cadranel

Showing results (531-540 of 709) with videos related to

Pageof 71
Sort By:
Respiratory Medicine and Research|December 18, 2024
Evaluation of efficacy and safety of rituximab in patients with progressive interstitial lung disease (ILD) with inflammatory component (EvER-ILD2): A multicentre double-blind placebo-controlled randomized trialMarion Ferreira, Theodora Bejan-Angoulvant, Sylvain Marchand-Adam, et al.
Alimentary Pharmacology & Therapeutics|July 29, 2008
Interaction of ribavirin with azathioprine metabolism potentially induces myelosuppressionL Peyrin-Biroulet, J-F Cadranel, J-B Nousbaum, et al.
Alimentary Pharmacology & Therapeutics|October 20, 2007
Coeliac disease in chronic hepatitis C: a French multicentre prospective studyT Thevenot, J Denis, V Jouannaud, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 25, 2019
Phase II Study of Roniciclib in Combination with Cisplatin/Etoposide or Carboplatin/Etoposide as First-Line Therapy in Patients with Extensive-Disease Small Cell Lung CancerMartin Reck, Leora Horn, Silvia Novello, et al.
BMC Gastroenterology|November 14, 2006
Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver diseaseThierry Poynard, Vlad Ratziu, Frederic Charlotte, et al.
Medicine|August 12, 2022
Fibroscan® and Shear Wave correlated well in hepatic fibrosis evaluation of patients with chronic liver diseases "in real life situation"Honoré Tegwendé Zougmoré, Jean François David Cadranel, Gildas Fantognon, et al.
Journal of Pediatric Gastroenterology and Nutrition|March 30, 2018
Chapter 8. 50 Years of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN): Captivating Witness Reports of a Success StorySalvatore Auricchio, Samy Cadranel, Stefano Guandalini, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 27, 2014
Lung cancer in combined pulmonary fibrosis and emphysema: a series of 47 Western patientsNicolas Girard, Sylvain Marchand-Adam, Jean-Marc Naccache, et al.
ERJ Open Research|April 26, 2018
Efficacy of next treatment received after nivolumab progression in patients with advanced nonsmall cell lung cancerAdrien Costantini, Jennifer Corny, Vincent Fallet, et al.
Mabs|December 9, 2014
VEGF neutralizing aerosol therapy in primary pulmonary adenocarcinoma with K-ras activating-mutationsVirginie Hervé, Nathalie Rabbe, Laurent Guilleminault, et al.
Pageof 71

Showing results (531-540 of 709) with videos related to

Sort By:
Pageof 71
Respiratory Medicine and Research|December 18, 2024
Evaluation of efficacy and safety of rituximab in patients with progressive interstitial lung disease (ILD) with inflammatory component (EvER-ILD2): A multicentre double-blind placebo-controlled randomized trialMarion Ferreira, Theodora Bejan-Angoulvant, Sylvain Marchand-Adam, et al.
Alimentary Pharmacology & Therapeutics|July 29, 2008
Interaction of ribavirin with azathioprine metabolism potentially induces myelosuppressionL Peyrin-Biroulet, J-F Cadranel, J-B Nousbaum, et al.
Alimentary Pharmacology & Therapeutics|October 20, 2007
Coeliac disease in chronic hepatitis C: a French multicentre prospective studyT Thevenot, J Denis, V Jouannaud, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 25, 2019
Phase II Study of Roniciclib in Combination with Cisplatin/Etoposide or Carboplatin/Etoposide as First-Line Therapy in Patients with Extensive-Disease Small Cell Lung CancerMartin Reck, Leora Horn, Silvia Novello, et al.
BMC Gastroenterology|November 14, 2006
Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver diseaseThierry Poynard, Vlad Ratziu, Frederic Charlotte, et al.
Medicine|August 12, 2022
Fibroscan® and Shear Wave correlated well in hepatic fibrosis evaluation of patients with chronic liver diseases "in real life situation"Honoré Tegwendé Zougmoré, Jean François David Cadranel, Gildas Fantognon, et al.
Journal of Pediatric Gastroenterology and Nutrition|March 30, 2018
Chapter 8. 50 Years of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN): Captivating Witness Reports of a Success StorySalvatore Auricchio, Samy Cadranel, Stefano Guandalini, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 27, 2014
Lung cancer in combined pulmonary fibrosis and emphysema: a series of 47 Western patientsNicolas Girard, Sylvain Marchand-Adam, Jean-Marc Naccache, et al.
ERJ Open Research|April 26, 2018
Efficacy of next treatment received after nivolumab progression in patients with advanced nonsmall cell lung cancerAdrien Costantini, Jennifer Corny, Vincent Fallet, et al.
Mabs|December 9, 2014
VEGF neutralizing aerosol therapy in primary pulmonary adenocarcinoma with K-ras activating-mutationsVirginie Hervé, Nathalie Rabbe, Laurent Guilleminault, et al.
Pageof 71